LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Pregabalin to improve postoperative recovery in bariatric surgery: a parallel, randomized, double-blinded, placebo-controlled study.

Martins, Marcelo J / Martins, Caroline Paiva Matos Oliveira / Castro-Alves, Lucas J / Jesus, Gabriel Nascimento / Campos, Guilherme Oliveira / Sacramento, Breno Barbosa Cerqueira / Borges, Leonardo Ferrari / Mello, Carlos Augusto Bastos / Alves, Rodrigo Leal / Módolo, Norma Sueli Pinheiro

Journal of pain research

2018  Volume 11, Page(s) 2407–2415

Abstract: Purpose: Obesity has been considered as a major public health problem in developed countries for which bariatric surgery has become an important treatment strategy. Postoperative pain, however, is a frequent problem in postoperative management. ... ...

Abstract Purpose: Obesity has been considered as a major public health problem in developed countries for which bariatric surgery has become an important treatment strategy. Postoperative pain, however, is a frequent problem in postoperative management. Pregabalin blocks the development of hyperalgesia and central pain sensitization. The objective of this randomized, placebo-controlled, double-blinded trial was to evaluate the effect of a single dose of preoperative pregabalin vs placebo on the quality of postoperative recovery in patients undergoing bariatric surgery.
Patients and methods: A total of 70 patients undergoing abdominal gastroplasty were randomly assigned to receive oral pregabalin (75 mg) or an identical placebo 1 hour before surgery. The primary outcome was Quality of Recovery-40 (QoR-40) score at 24 hours. Secondary outcomes included opioid consumption and postoperative pain scores.
Results: In all, 60 of the 70 patients completed the study. The mean (SD) global recovery scores (QoR-40) 24 hours after surgery in the pregabalin and control groups were 183.7 (9) and 182.1 (12), respectively (mean difference=1.6, 95% CI -7.36 to 4.2,
Conclusion: In patients who underwent bariatric surgery, a single preoperative dose of pregabalin (75 mg) did not improve pain relief, quality of postoperative recovery, or reduction in opioid consumption.
Clinical trial registration: http://www.ensaiosclinicos.gov.br (identifier: RBR-2g89x8).
Language English
Publishing date 2018-10-17
Publishing country New Zealand
Document type Journal Article
ZDB-ID 2495284-9
ISSN 1178-7090
ISSN 1178-7090
DOI 10.2147/JPR.S176468
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top